- Home
- ELP vs RVMD Comparison
ELP vs RVMD Comparison
Compare ELP & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELP
- RVMD
- Stock Information
- Founded
- ELP 1954
- RVMD 2014
- Country
- ELP Brazil
- RVMD United States
- Employees
- ELP N/A
- RVMD N/A
- Industry
- ELP Electric Utilities: Central
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELP Utilities
- RVMD Health Care
- Exchange
- ELP Nasdaq
- RVMD Nasdaq
- Market Cap
- ELP 6.2B
- RVMD 7.5B
- IPO Year
- ELP 1997
- RVMD 2020
- Fundamental
- Price
- ELP $8.96
- RVMD $38.95
- Analyst Decision
- ELP
- RVMD Strong Buy
- Analyst Count
- ELP 0
- RVMD 13
- Target Price
- ELP N/A
- RVMD $69.85
- AVG Volume (30 Days)
- ELP 214.9K
- RVMD 2.1M
- Earning Date
- ELP 08-06-2025
- RVMD 08-06-2025
- Dividend Yield
- ELP 4.93%
- RVMD N/A
- EPS Growth
- ELP 30.24
- RVMD N/A
- EPS
- ELP 0.19
- RVMD N/A
- Revenue
- ELP $4,381,150,343.00
- RVMD N/A
- Revenue This Year
- ELP N/A
- RVMD N/A
- Revenue Next Year
- ELP $6.59
- RVMD $387.56
- P/E Ratio
- ELP $11.34
- RVMD N/A
- Revenue Growth
- ELP 8.47
- RVMD N/A
- 52 Week Low
- ELP $5.72
- RVMD $29.17
- 52 Week High
- ELP $9.34
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- ELP 51.83
- RVMD 58.62
- Support Level
- ELP $8.80
- RVMD $37.56
- Resistance Level
- ELP $8.99
- RVMD $40.98
- Average True Range (ATR)
- ELP 0.15
- RVMD 1.46
- MACD
- ELP -0.01
- RVMD 0.41
- Stochastic Oscillator
- ELP 55.26
- RVMD 63.49
About ELP Companhia Paranaense de Energia (COPEL)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.